reference/31539135

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31539135

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	5396
issn	0732-183X 1527-7755
issueIdentifier	34
pageRange	5390-5396
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	5390
bibliographicCitation	Scope A, Agero AL, Dusza SW, Myskowski PL, Lieb JA, Saltz L, Kemeny NE, Halpern AC. Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. J Clin Oncol. 2007 Dec 01;25(34):5390–6. doi: 10.1200/jco.2007.12.6987. PMID: 18048820.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9160-7411 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fecb07718873f79e7a91b216235c903 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcc2f31dd19e389bc089cb2fbeda8df2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca52147d01eb213747f22e64e7645ba4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8747dd121e6b3ec6b5a1ef20aa7b2e66 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d422234dbd3196adc13733cee78cba4c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05cecac33f65eb025d28e590695b73d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a0261b0b0046403ec68c84ac3bbe190 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4a316a94f3c14c491d64ebf54756952
date	2007-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2007.12.6987 https://pubmed.ncbi.nlm.nih.gov/18048820
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Randomized Double-Blind Trial of Prophylactic Oral Minocycline and Topical Tazarotene for Cetuximab-Associated Acne-Like Eruption
discusses	http://id.nlm.nih.gov/mesh/M0014839 http://id.nlm.nih.gov/mesh/M0230113 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0016932 http://id.nlm.nih.gov/mesh/M0013912 http://id.nlm.nih.gov/mesh/M0422675 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0006057
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015179Q000188 http://id.nlm.nih.gov/mesh/D017486Q000517 http://id.nlm.nih.gov/mesh/D003879Q000008 http://id.nlm.nih.gov/mesh/D009539Q000008 http://id.nlm.nih.gov/mesh/D000911Q000009 http://id.nlm.nih.gov/mesh/D008911Q000008 http://id.nlm.nih.gov/mesh/D000970Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000068818 http://id.nlm.nih.gov/mesh/D000287 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D017486Q000139 http://id.nlm.nih.gov/mesh/D010919 http://id.nlm.nih.gov/mesh/D066246Q000037 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D000369
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8995 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10030 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6777 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675783 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5381 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128806208 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129979483

Total number of triples: 72.